Leukaemia researcher and clinical haematologist Associate Professor Steven Lane has been appointed as the new Head of the Cancer Program at QIMR Berghofer Medical Research Institute.
Associate Professor Lane will perform his new role in addition to his duties as Group Leader of the Gordon and Jessie Gilmour Leukaemia Research laboratory, where his team is investigating new treatments for myeloid disorders.
QIMR Berghofer’s Director and CEO Professor Frank Gannon welcomed Associate Professor Lane’s appointment.
“Steven Lane is dedicated to finding new cures for leukaemia in his laboratory here at QIMR Berghofer, and, significantly for our research translation activities, he is also a working clinical haematologist at the Royal Brisbane and Women’s Hospital where he helps patients on the frontline,” he said.
“He obtained his medical degree from the University of Queensland and subsequently finished his clinical training right here in Brisbane.
“Shortly afterward, he undertook a research fellowship at Harvard Medical School in the United States where he focused on finding new treatments for acute myeloid leukaemia.
“He is an outstanding clinician and researcher and I am thrilled he has agreed to be our new Head of the Cancer Program.
“The Cancer Program at the Institute is performing transformative work.
“The combination of Associate Professor Lane’s research and clinical expertise will be an asset to this team.”